---
title: Quality of Life and Sexual Function of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect
nct_id: NCT01978067
overall_status: UNKNOWN
sponsor: Shu-Qin Chen
study_type: OBSERVATIONAL
primary_condition: Quality of Life
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01978067.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01978067"
ct_last_update_post_date: 2014-02-27
last_seen_at: "2026-05-12T07:19:07.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Quality of Life and Sexual Function of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect

**Official Title:** Safety ,Validity and Quality of (Sexual)Life of Vaginal Operation in The Treatment Of Previous Cesarean Scar Defect

**NCT ID:** [NCT01978067](https://clinicaltrials.gov/study/NCT01978067)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** Shu-Qin Chen
- **Conditions:** Quality of Life, Sexual Activity
- **Start Date:** 2013-01
- **Completion Date:** 2015-12
- **CT.gov Last Update:** 2014-02-27

## Brief Summary

The aim of this study is to further demonstrate the safety , validity and quality of (sexual)life of vaginal operation for previous cesarean scar defect resection.

## Detailed Description

collect all the patients'clinical information,use two questionnaire (the HRQoL and FSFI)to estimate patients' general healthy and sexual function before surgery and postoperation in 1 month,3 months and 6 months

## Eligibility

- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* preoperative diagnosed as PCSD
* hemodynamic stability

Exclusion Criteria:

* irregular menstrual cycle
* using IUD
* complicating other disease also causing vaginal bleeding,such as endometrial polyp,submucous myoma and functional uterine bleeding.
```

## Arms

- **transvaginal resection of Uterine Scar** — transvaginal resection of Uterine Scar From Previous Cesarean Delivery

## Interventions

- **transvaginal resection of Uterine Scar** (PROCEDURE) — Expose, grasp and traction the cervix. An incision was made at the anterior cervicovaginal junction, and the bladder was dissected away until the anterior peritoneal reflection was identified. The anterior drawing hook was inserted.into the vaginal incision to retract the bladder upwards. The PCSD was identified as a'fornix' located in the anterior part of the lower uterine segment. A transverse incision was made to remove the scar deficiency, and the edges of the incision were trimmed with scissors, and the myometrial and vaginal defects were closed.

## Primary Outcomes

- **The safety of transvaginal resection of caesarean scar deficiency in the treatment of PCSD** _(time frame: one week)_ — blood loss, hemoglobin in the first postoperative day, operation time, preoperative and postoperative complications,change to other treatment,vaginal bleeding after surgery and length of stay are collected to evaluate the safety of this procedure.

## Secondary Outcomes

- **the effectiveness of transvaginal resection of caesarean scar deficiency in the treatment of PCSD.** _(time frame: one year)_

## Locations (1)

- The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.the first affiliated hospital of sun yat-sen university|guangzhou|guangdong|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01978067.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01978067*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*